Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Prelude Therapeutics at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Prelude Therapeutics brings 2 presentations to Discovery on Target 2026 in Boston. Its program centres on precision degrader-antibody conjugates as an emerging modality for targeted therapy, and on the pros and cons of degrader conjugates.

OrganizationDiscovery on Target 2026 Attendance
Prelude Therapeutics
Wilmington, DE
preludetx.com
Biotech
Oncology biotech developing precision cancer medicines, including SMARCA2 degraders and degrader-antibody conjugates.
Panel
Thu Oct 1
7:30am–8:15am
Pros and Cons of Degrader Conjugates
Novel Drug Modalities · with SUNY Upstate Medical University, Cullgen
Talk
Thu Oct 1
9:45am–10:05am

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Prelude Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction